Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
![Лого](https://financialmodelingprep.com/image-stock/DRNA.png)
Dicerna Pharmaceuticals, Inc. DRNA
$38.22
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
40.14
-
week52low
19.06
-
Revenue
164307000
-
P/E TTM
-25
-
Beta
0.78597400
-
EPS
0.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 ноя 2021 г. в 05:00
Описание компании
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-mediated diseases; and neurodegenerative diseases and pain. Its principal development programs include nedosiran for the treatment of primary hyperoxaluria; RG6346 for the treatment of chronic hepatitis B virus infection; belcesiran for the treatment of deficiency-associated liver disease; and DCR-AUD for the treatment of alcohol use disorder. Dicerna Pharmaceuticals, Inc. has strategic collaborations with Novo Nordisk A/S, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of December 27, 2021, Dicerna Pharmaceuticals, Inc. operates as a subsidiary of Novo Nordisk A/S.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Chardan Capital | Neutral | Buy | 09 дек 2021 г. |
RBC Capital | Sector Perform | Outperform | 19 ноя 2021 г. |
HC Wainwright & Co. | Neutral | Buy | 18 ноя 2021 г. |
Goldman Sachs | Neutral | Buy | 11 авг 2021 г. |
HC Wainwright & Co. | Buy | Buy | 10 авг 2021 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
HOFFMAN STEPHEN J | D | 0 | 15000 | 28 дек 2021 г. |
HOFFMAN STEPHEN J | D | 0 | 16157 | 28 дек 2021 г. |
Aradhye Shreeram | D | 0 | 51070 | 28 дек 2021 г. |
Aradhye Shreeram | D | 0 | 51070 | 28 дек 2021 г. |
Aradhye Shreeram | D | 0 | 6973 | 28 дек 2021 г. |
Brown Bob D | D | 0 | 68100 | 28 дек 2021 г. |
Brown Bob D | D | 0 | 68100 | 28 дек 2021 г. |
Brown Bob D | D | 0 | 2367 | 28 дек 2021 г. |
BUCHI J KEVIN | D | 0 | 15000 | 28 дек 2021 г. |
BUCHI J KEVIN | D | 0 | 15000 | 28 дек 2021 г. |
Свежие комментарии
Свежие комментарии